Synopsys, Inc. SNPS is slated to release first-quarter fiscal 2019 results on Feb 20.
Notably, the company surpassed the Zacks Consensus Estimate in two of the trailing four reported quarters and matched it twice, the average beat being 3.32%.
In the last reported quarter, the company’s bottom and top-line figures met the Zacks Consensus Estimate. The results marked a year-over-year improvement.
For the fiscal first quarter, the company anticipates revenues in the $775-$810 million range. Non-GAAP earnings per share are expected within 95 cents to a penny.
The Zacks Consensus Estimate for revenues and earnings per share is pegged at $796.7 million and 97 cents, respectively.
Let’s see, how things are shaping up prior to this announcement.
Factors at Play
Synopsys is gaining traction from a solid uptick across all product groups and geographies. Its sustained focus on introducing products, acquisitions and deal wins is likely to continue boosting results.
Robust trends in the core electronic design automation (EDA) market, driven by a consistent chip and system complexity, is a positive. The company’s digital design tools, aided by a strong performance across its Fusion design platform, are helping it generate solid revenue growth.
Demand for Synopsys’ hardware-based Zebu emulation system is also encouraging. Also, sturdy growth in both the IP and Software Integrity segments is setting the stage for further expansion. The company is looking into both organic investments and key buyouts to diversify its customer base, thus expanding its total addressable market.
Management noted that the company’s purchases of Cigital and Black Duck are establishing tactical quality relations with clients, leading to higher demand creation, cross-selling and a substantial rise in brand recognition.
However, U.S.-China trade tensions and slowing smartphone demand are a major threat to semiconductor market, which makes us grow anxious about Synopsys’s near-term results.
Further, increasing costs and expenses are an overhang on the company’s margins. Additionally, a rising competition from the likes of Cadence Design Systems Inc. CDNS is another concern.
Synopsys, Inc. Price and EPS Surprise
Synopsys, Inc. Price and EPS Surprise | Synopsys, Inc. Quote
What Our Model Says
Our proven Zacks model clearly shows that a company with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) has a good chance of beating estimates if it also has a positive Earnings ESP. Zacks Rank #4 (Sell) or #5 (Strong Sell) stocks are best avoided. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Synopsys currently carries a Zacks Rank #2, which increases the predictive power of ESP. However, its Earnings ESP of 0.00% makes surprise prediction difficult.
Here are some stocks, which you may consider as our model shows that these have the right combination of elements to beat on earnings in the upcoming releases:
GTT Communications, Inc. GTT has an Earnings ESP of +173.53% and a Zacks Rank of 2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Ciena Corporation CIEN has an Earnings ESP of +1.70% and a Zacks Rank #3.
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
It's not the one you think.
See This Ticker Free >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
GTT Communications, Inc. (GTT) : Free Stock Analysis Report
Synopsys, Inc. (SNPS) : Free Stock Analysis Report
Cadence Design Systems, Inc. (CDNS) : Free Stock Analysis Report
Ciena Corporation (CIEN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research